Shanghai Hile Bio-Technology News

Hailey Biotech (603718): The non-plague epidemic drags down performance insurance+people's insurance enhances long-term performance

中信建投證券Sep 2, 2019 00:00

Haili Biology (603718): layout Vaccine CDMO Service to the Global Vaccine Market

國泰君安May 22, 2019 00:00

Haili Biology (603718): short-term decline in performance is optimistic about the long-term development of animal insurance + PICC.

中信建投證券Mar 25, 2019 00:00

Haili Biological (603718) 15-year mid-year review: the warming of the breeding market will drive the demand for foot-and-mouth disease vaccine project to establish long-term growth.

中原證券Dec 25, 2018 00:00

Haili Bio (603718) semi-annual report comments: process transformation period semi-annual report income performance decline animal insurance + PICC platform has emerged

天風證券Sep 3, 2018 00:00

KuaiBao of Haili Biological (603718) Co., Ltd.: hold hands with Wuxi Biologics to get involved in the PICC business in the field of human vaccines and the next city.

華金證券Jul 20, 2018 00:00

Comments on Haili Bio (603718) Annual report and Quarterly report: the distribution of PICC in animal protection business has been accelerated.

中信證券Apr 27, 2018 00:00

Haili biology (603718) update report: animal insurance, people's insurance ballroom dance ready for a new journey

國泰君安Apr 3, 2018 00:00

Haili Biological (603718) Quarterly report comments: the impact of recruitment adjustment continues to pay attention to the release of foot-and-mouth disease seedlings.

廣發證券Nov 1, 2017 00:00

Haili Biological (603718) three-quarter report comments: sound performance of new products of foot-and-mouth disease on the market is expected to accelerate performance!

安信證券Oct 30, 2017 00:00

Hailey Biotech (603718) Interim Report: The inflection point of performance is gradually evident, and the foot-and-mouth disease market is setting sail

中信證券Aug 29, 2017 00:00

Hailey Biotech (603718) Semi-Annual Report Review: Foot-and-mouth Disease Vaccine Leads New Product, Animal Insurance and Human Insurance Complement Each Other

西南證券Aug 29, 2017 00:00

海利生物(603718)：困境中“逆袭“ 下半年公司业绩有望迎来“拐点“！

天風證券Aug 28, 2017 00:00

Hailey Biotech (603718) Semi-Annual Report Review: The inflection point is now moving forward at an accelerated pace

國泰君安Aug 28, 2017 00:00

Hailey Biotech (603718) Interim Report: Optimizing the product structure and launching the foot-and-mouth disease vaccine is expected to drive the company's new growth!

安信證券Aug 28, 2017 00:00

Hailey Biotech (603718) review: Foot-and-mouth disease is new and sales are worth looking forward to

天風證券Jul 10, 2017 00:00

Haili Biological (603718) Company covers for the first time: the inflection point is becoming clear.

國泰君安May 4, 2017 00:00

Hailey Biotech (603718) quarterly report review: The lack of revenue from subsidiaries is dragging down the company's performance. The launch of the foot-and-mouth disease vaccine is expected to drive performance growth!

安信證券May 2, 2017 00:00

Hailey Biotech (603718) Company Report: The foot-and-mouth disease vaccine has obtained production approval and is about to be marketed and is expected to contribute to increased performance!

安信證券Apr 27, 2017 00:00

Hailey Biotech (603718) Annual Report Review: Yang Ling Jinhai Drags Down Performance Foot-and-Mouth Vaccine Will Support Future Performance Growth

廣發證券Apr 24, 2017 00:00